Total | Non-AKI | AKI | p value | Non-septic | Septic | p value | |
---|---|---|---|---|---|---|---|
n | 98 | 49 | 49 | – | 58 | 40 | – |
Men | 65 (66.3%) | 30 (61.2%) | 35 (71.4%) | NS | 38 (65.5%) | 27 (67.5%) | NS |
Age (years) | 55 ± 17.3 | 50.4 ± 17.9 | 59.9 ± 15.5 | 0.006 | 50.9 ± 16.6 | 61.2 ± 16.8 | 0.003 |
Renal characteristics | |||||||
Baseline eGFR (mL/min) n = 86 | 110.6 ± 53.7 | 120.5 ± 60.5 | 100.7 ± 44.6 | NS | 121.9 ± 58.9 | 94.8 ± 41.2 | 0.020 |
Baseline creatinine (μmol/L) n = 86 | 79 ± 31.5 | 80.5 ± 32.3 | 78.1 ± 31.1 | NS | 79.6 ± 28.9 | 78.9 ± 35.1 | NS |
Creatinine upon ICU admission | 94.1 ± 42.2 | 74.6 ± 30.2 | 113.1 ± 43.9 | <0.001 | 85.0 ± 36.8 | 106.9 ± 46.5 | 0.015 |
AKI at admission | 44 (44.9%) | – | 44 (89.8%) | – | 20 (34.5%) | 24 (60%) | 0.013 |
AKIN ≥ 2 upon ICU admission | 25 (25.5%) | – | 25 (51%) | – | 9 (15.5%) | 16 (40%) | 0.009 |
Renal replacement <48 h | 5 (5.1%) | 0 (0%) | 5 (10.2%) | 0.056 | 4 (6.9%) | 1 (2.5%) | NS |
Worst value [TIMP-2]·[IGFBP7] ((ng/mL)2/1000) | 0.41 (0.20–1.36) | 0.24 (0.11–0.48) | 1.03 (0.38–3.29) | <0.001 | 0.36 (0.14–1.08) | 0.56 (0.26–2.94) | NS |
ICU epidemiological data | |||||||
Shock | 35 (35.7%) | 11 (22.5%) | 24 (50%) | 0.011 | 10 (17.2%) | 25 (62.5%) | <0.001 |
Septic shock | 19 (19.4%) | 6 (12.3%) | 13 (26.5%) | NS | – | 19 (47.5%) | – |
Mechanical ventilation | 79 (80.6%) | 39 (79.6%) | 40 (81.6%) | NS | 44 (75.9%) | 35 (87.5%) | NS |
SAPS II | 37.4 ± 18.3 | 30.9 ± 14.9 | 43.9 ± 19.2 | <0.001 | 30.9 ± 15.6 | 46.8 ± 18.1 | <0.001 |
APACHE II | 15.7 ± 8.2 | 13.5 ± 7.7 | 17.9 ± 8.2 | 0.007 | 14.2 ± 8.5 | 17.9 ± 7.3 | 0.024 |
SOFA at ICU admission | 7.5 ± 3.7 | 6.1 ± 3.2 | 8.9 ± 3.7 | <0.001 | 6.7 ± 3.7 | 8.7 ± 3.4 | 0.009 |
ICU LOS (days) | 11.1 ± 14.6 | 10.0 ± 10.6 | 12.3 ± 18.8 | NS | 9.3 ± 11.0 | 13.9 ± 18.5 | NS |
Hospital LOS (days) | 23.6 ± 25.0 | 23.4 ± 23.3 | 23.8 ± 27.0 | NS | 21.4 ± 21.3 | 26.9 ± 29.6 | NS |
ICU mortality | 10 (10.2%) | 4 (8.2%) | 6 (12.3%) | NS | 6 (10.3%) | 4 (10%) | NS |